Vaccine Availability Update

The FDA is expected to make crucial decisions regarding the authorization of Covid vaccines for children under five, with Moderna and Pfizer providing data on their trials. While the effectiveness rates may seem low, the focus is on preventing severe illness rather than just infection. Pediatricians anticipate a continued need for more doses, especially as booster shots may be recommended for young children.